K2J2 Sp. z o.o.

The clinical trials at Centrum Medyczne K2J2 in Wołomin focus strongly on immune system diseases and musculoskeletal diseases, especially psoriatic arthritis, axial spondyloarthritis, and Sjögren’s disease. These studies are designed to assess new treatment options, compare them with placebo, and better understand symptom control and disease activity.

• Testing new therapies for active psoriatic arthritis and related inflammatory joint conditions
• Evaluating treatment effectiveness in axial spondyloarthritis
• Studying approaches for Primary Sjögren’s Disease and broader autoimmune disease management

Several trials aim to improve long-term symptom relief, reduce systemic inflammation, and support better day-to-day functioning for people living with chronic autoimmune conditions.

This research site also contributes to respiratory tract diseases and related environment and public health topics, with studies in bronchiectasis, refractory chronic cough, and common upper respiratory infections such as rhinitis, rhinopharyngitis, and rhinosinusitis. The main goal is to evaluate whether new therapies can ease symptoms and improve respiratory outcomes.

• Assessing treatments for bronchiectasis and reducing flare-ups
• Investigating options for refractory or unexplained chronic cough
• Studying non-antibiotic care for acute rhinitis, rhinopharyngitis, and rhinosinusitis

These trials are aimed at improving comfort, lowering symptom burden, and finding better ways to manage frequent airway and nasal conditions.

The site is active in immune system phenomena and immune system processes, including studies of birch pollen-induced allergic rhinitis and rhinoconjunctivitis. Research in this area focuses on testing whether new interventions can reduce allergic symptoms and improve control of seasonal reactions.

• Evaluating therapies for birch pollen allergy
• Improving symptom control in allergic rhinitis and rhinoconjunctivitis
• Exploring new ways to manage inflammatory immune responses

These studies help clarify how to better support patients with recurring allergy-related discomfort and immune-driven inflammation.

Clinical research at this site includes work on influenza, reflecting interest in respiratory infections and public health. The studies are intended to examine treatment response and help better understand how antiviral approaches perform in real-world patient groups.

• Studying influenza treatment effectiveness
• Assessing how antiviral therapy may influence infection control
• Supporting broader research into respiratory virus management

This area of research contributes to improved understanding of how to manage seasonal viral illness and its impact on patients and households.

The trial portfolio also includes psychiatry and psychology, with a focus on behavior and behavior mechanisms related to electronic cigarette cessation. This research examines whether medication support combined with counseling can help people quit vaping or dual use of vaping and smoking.

• Testing support strategies for nicotine-containing electronic cigarette cessation
• Evaluating behavioral support for stopping vaping and smoking
• Studying real-world quit outcomes in motivated adults

By combining medical and behavioral approaches, these studies aim to improve quit rates and support healthier long-term habits.

Another important focus at K2J2 Sp. z o.o. is skin and connective tissue diseases, especially inflammatory conditions that overlap with rheumatology and immunology. The trials are designed to test new therapies and evaluate how well they control disease activity over time.

• Investigating treatment options for psoriatic arthritis
• Exploring therapies that target chronic inflammatory disease
• Assessing longer-term safety and tolerability in immune-mediated conditions

This work supports the search for better symptom relief and more durable disease control in patients with persistent inflammatory disorders.